KBC Securities advice for Pfizer
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| January 29, 2019 | KBC Securities | Pfizer | Sell | 40.50 USD | 0.84 % |
Advice details
Brussels - Op 29 jan herhalen de analisten van KBC Securities hun verkoopadvies voor het Amerikaanse farmaceutisch concern Pfizer (ISIN: US7170811035 / Mnemo: PFE). Het 12-maands koersdoel is vastgesteld op 40.5 USD
Back
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2024 ValueSpectrum. All Rights Reserved
Developed and maintained by 